Skip to content
Evaluation CAPES Module #3: Spondyloarthritis (SpA) and Psoriatic Arthritis (PsA) Treatment Update
Demographic Questions
1.
Please provide your name and email address.
Name
Email Address
2.
What is your specialty?
Dermatology
Rheumatology
Primary Care
Other (please specify)
3.
Please indicate your practice setting.
Academic
Community
4.
Number of patients seen/impacted per week.
Activity Objectives: Please rate your level of achievement.
5.
Review treatment recommendations for the clinical domains of psoriatic arthritis: peripheral arthritis, spine disease, enthesitis, dactylitis, skin and nail disease, and associated conditions of inflammatory bowel disease and uveitis.
Outstanding
Good
Average
Fair
Poor
6.
Review data for individual drugs that have been approved or are due to be approved for PsA.
Outstanding
Good
Average
Fair
Poor
7.
Learn treatment options for the patient who has “tried everything.”
Outstanding
Good
Average
Fair
Poor
8.
Review the current treatment paradigm for axial SpA.
Outstanding
Good
Average
Fair
Poor
9.
Identify unmet needs and discuss future directions in the management of axial SpA.
Outstanding
Good
Average
Fair
Poor
Evaluation of the Presenters
10.
The
delivery
of the presentation given by Philip Mease, MD, was:
Outstanding
Good
Average
Fair
Poor
11.
The
content
of the presentation given by Philip Mease, MD, was:
Outstanding
Good
Average
Fair
Poor
12.
Did Philip Mease, MD, appear
objective
and
unbiased
by commercial interests?
Yes
No
If no, please explain:
13.
The
content
of the presentation given by Joerg Ermann, MD, was:
Outstanding
Good
Average
Fair
Poor
14.
The
delivery
of the presentation given by Joerg Ermann, MD, was:
Outstanding
Good
Average
Fair
Poor
15.
Did Joerg Ermann, MD, appear
objective
and
unbiased
by commercial interests?
Yes
No
If no, please explain:
16.
The
content
of the presentation given by Roz Tolliver was:
Outstanding
Good
Average
Fair
Poor
17.
The
delivery
of the presentation given by Roz Tolliver was:
Outstanding
Good
Average
Fair
Poor
18.
Did Roz Tolliver appear
objective
and
unbiased
by commercial interests?
Yes
No
If no, please explain:
19.
The
content
of the presentation given by John Latella was:
Outstanding
Good
Average
Fair
Poor
20.
The
delivery
of the presentation given by John Latella was:
Outstanding
Good
Average
Fair
Poor
21.
Did John Latella appear
objective
and
unbiased
by commercial interests?
Yes
No
If no, please explain:
22.
As a moderator, Atul Deodhar, MD, MRCP, was:
Outstanding
Good
Average
Fair
Poor
Relevance and Application
23.
Was the information in this activity relevant to your practice or professional development?
Yes
No
24.
I learned new information about SpA and PsA as a result of this program.
Yes
No
25.
Based on the information you received today, do you plan on changing your practice?
Yes, I intend to change the therapy that I render
Yes, I intend to alter the way that I evaluate my patients
Yes, I intend to change the legal/documentation/financial management of my practice
Yes, it may affect my patient referrals
No, but it did confirm my current practice
No, because it doesn’t directly apply to my practice
No, but it did increase my knowledge of community resources
No, because the information was inadequate and/or inaccurate
Other (please elaborate)
26.
How would you rate the presentation overall?
Outstanding
Good
Average
Fair
Poor
27.
Please let us know about any other comments you have:
